With the potential for a sizable correction looming and interest rates at the lowest levels since February, it may be a good idea for investors to consider Dividend Aristocrats that are in…
Warren Buffett reduced Berkshire Hathaway's holdings in 13 stocks during the first quarter of this year. Here's how eight of those stocks have performed so far in the second quarter.
Here are four companies with huge market caps that pay big dividends and have for a long time.
With the potential for a sizable market correction looming, it might be a good idea for investors to look at stocks on the Dividend Aristocrats list that are in sectors poised to…
America's two largest energy companies report March quarter results Friday morning, along with two big pharmaceutical makers.
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
With the stock market very overbought and interest rates still very close to generational lows, top-quality dividend stocks may be the way to go for the rest of 2021. Here are five…
Rome was not built in a day, and neither are multibillion-dollar corporations. Biopharmaceuticals company AbbVie is the largest American company founded in the past decade.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Wednesday's top analyst upgrades and downgrades included AbbVie, Albertsons, DuPont, Exxon Mobil, Home Depot, KB Home, Mastercard, Palantir and Twitter.
With even moderate appreciation in the shares prices of these top companies, investors could be looking at double-digit total return potential. In a market that is very long in the tooth, that…
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Wednesday's top analyst upgrades and downgrades included Baidu, BigCommerce, Boeing, Ciena, Deere, GoodRx, Kohl's, ONEOK, Tesla and Walmart.
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
